Pharma Deals Review, Vol 2009, No 6 (2009)

Font Size:  Small  Medium  Large

Watson Acquires Arrow in Bid for International Expansion

Taskin Ahmed

Abstract


Watson Pharmaceuticals is to acquire the generic drug company, Arrow Group, for US$ 1.75 B in a bid to expand beyond the US. By doing so it also acquired US rights to the generic version of the world’s leading cholesterol lowering drug, Lipitor® (atorvastatin).



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.